Results 281 to 290 of about 89,117 (340)
Some of the next articles are maybe not open access.

Bisphosphonate Prodrugs

Current Medicinal Chemistry, 2002
Bisphosphonates (BP) are pyrophosphate analogs having a P-C-P backbone. The oral bioavailability of BPs is ca. 1%, due to high ionisation at physiological pH. Using the prodrug approach, oral absorption can be increased by masking one or more ionizable groups (clodronate, etidronate), or using a targeting carrier system (alendronate, pamitronate).
openaire   +2 more sources

Bisphosphonates

Reactions Weekly, 2008
Anke J. Roelofs   +4 more
  +5 more sources

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

Journal of oral and maxillofacial surgery, 2009
S. Ruggiero   +5 more
semanticscholar   +1 more source

Consensus guidelines on the use of bisphosphonate therapy in children and adolescents

Journal of Paediatrics and Child Health, 2018
P. Simm   +14 more
semanticscholar   +1 more source

Bisphosphonate holidays

Drug and Therapeutics Bulletin, 2021
openaire   +2 more sources

A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?

Osteoporosis International, 2017
T. Hasegawa   +17 more
semanticscholar   +1 more source

Bisphosphonates

BMJ
Emma, Billington   +3 more
openaire   +3 more sources

Bisphosphonate considerations

British Dental Journal, 2012
C, Scully, A, Robinson
openaire   +2 more sources

Home - About - Disclaimer - Privacy